Los Angeles Measles Complication: Rare Fatal Case After Years
- A child in Los Angeles tragically passed away due to a rare and fatal complication of measles, years after initially recovering from teh infection. The case, reported by...
- Infant with measles spot on back | Image Credit: © airdone - stock.adobe.com
- "This case is a painful reminder of how risky measles can be, especially for our moast vulnerable community members," stated Muntu Davis, MD, MPH, Los angeles County Health...
Rare Measles complication Causes Death of Child in Los Angeles
Table of Contents
A child in Los Angeles tragically passed away due to a rare and fatal complication of measles, years after initially recovering from teh infection. The case, reported by the Los Angeles County Department of Public Health, underscores the serious nature of measles and the vital importance of vaccination.
Infant with measles spot on back | Image Credit: © airdone – stock.adobe.com
“This case is a painful reminder of how risky measles can be, especially for our moast vulnerable community members,” stated Muntu Davis, MD, MPH, Los angeles County Health Officer, in the official release.1 “Infants too young to be vaccinated rely on all of us to help protect them through community immunity. Vaccination is not just about protecting yourself-it’s about protecting your family, your neighbors, and especially children who are too young to be vaccinated.”
The child had previously contracted measles before becoming eligible for vaccination. The Centers for Disease Control and Prevention (CDC) recommends the first dose of the measles, mumps, and rubella (MMR) vaccine between 12 and 15 months of age, followed by a second dose between 4 and 6 years old, before school entry. Despite recovering from the initial measles infection, the child developed subacute sclerosing panencephalitis (SSPE), a rare and ultimately fatal complication.1,2
Understanding Subacute Sclerosing Panencephalitis (SSPE)
SSPE is a progressive and devastating brain disorder that arises as a very late complication of measles infection. It occurs in approximately 1 in 10,000 individuals who contract measles, but the risk increases to about 1 in 600 for those infected as infants. The condition is characterized by a gradual deterioration of neurological function. unfortunately, ther is currently no cure for SSPE, and patients typically survive for only 2 to 3 years after diagnosis.1
The Context: Rising Measles Cases and Declining Vaccination rates
This tragic event occurs against the backdrop of a concerning resurgence of measles cases in the United States and a decline in vaccination rates. As of September 10, 2025, over 1400 measles cases have been reported nationwide, marking the largest outbreak since measles was declared eradicated in 2000. This surpasses even the 2019 outbreak in New York’s Orthodox Jewish communities.
Several factors contribute to this increase, including:
- Decreased Vaccination Coverage: Falling vaccination rates leave more individuals susceptible to infection.
- Travel: International travel can introduce measles to unvaccinated populations.
- Misinformation: The spread of false or misleading information about vaccines contributes to vaccine hesitancy.
The Science Behind Measles and SSPE
Measles is a highly contagious viral infection that spreads through respiratory droplets. While most people recover from the initial infection,the measles virus can,in rare cases,persist in the body and lead to SSPE years later. SSPE develops when the measles virus mutates and attacks the brain, causing progressive neurological damage.
Here’s a breakdown of the timeline:
| Stage | Timeline | Characteristics |
|---|---|---|
| Initial Measles infection | Infancy/Early Childhood | Fever, cough, rash, and other typical measles symptoms. |